Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials.
Archer DF, Merkatz RB, Bahamondes L, Westhoff CL, Darney P, Apter D, Jensen JT, Brache V, Nelson AL, Banks E, Bártfai G, Portman DJ, Plagianos M, Dart C, Kumar N, Creasy GW, Sitruk-Ware R, Blithe DL. Archer DF, et al. Lancet Glob Health. 2019 Aug;7(8):e1054-e1064. doi: 10.1016/S2214-109X(19)30265-7. Epub 2019 Jun 20. Lancet Glob Health. 2019. PMID: 31231065 Free PMC article.
Segesterone acetate/ethinyl estradiol 12-month contraceptive vaginal system safety evaluation.
Gemzell-Danielsson K, Sitruk-Ware R, Creinin MD, Thomas M, Barnhart KT, Creasy G, Sussman H, Alami M, Burke AE, Weisberg E, Fraser I, Miranda MJ, Gilliam M, Liu J, Carr BR, Plagianos M, Roberts K, Blithe D. Gemzell-Danielsson K, et al. Contraception. 2019 Jun;99(6):323-328. doi: 10.1016/j.contraception.2019.02.001. Epub 2019 Mar 1. Contraception. 2019. PMID: 30831102 Free PMC article. Clinical Trial.
Bleeding profile associated with 1-year use of the segesterone acetate/ethinyl estradiol contraceptive vaginal system: pooled analysis from Phase 3 trials.
Vieira CS, Fraser IS, Plagianos MG, Burke AE, Westhoff CL, Jensen J, Brache V, Bahamondes L, Merkatz R, Sitruk-Ware R, Blithe DL. Vieira CS, et al. Contraception. 2019 Dec;100(6):438-444. doi: 10.1016/j.contraception.2019.07.145. Epub 2019 Aug 6. Contraception. 2019. PMID: 31398307 Free PMC article. Clinical Trial.
A randomized study on pharmacodynamic effects of vaginal rings delivering the progesterone receptor modulator ulipristal acetate: research for a novel estrogen-free, method of contraception.
Huang Y, Jensen JT, Brache V, Cochon L, Williams A, Miranda MJ, Croxatto H, Kumar N, Sussman H, Hoskin E, Plagianos M, Roberts K, Merkatz R, Blithe D, Sitruk-Ware R. Huang Y, et al. Contraception. 2014 Dec;90(6):565-74. doi: 10.1016/j.contraception.2014.08.006. Epub 2014 Aug 12. Contraception. 2014. PMID: 25193534 Free PMC article. Clinical Trial.
Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: A randomized proof-of-concept study.
Brache V, Vieira CS, Plagianos M, Lansiaux M, Merkatz R, Sussman H, Cochon L, Tejada AS, Kumar N, Loeven D, Blithe DL, Aprem AS, Williams AR, Kannan A, Bagchi IC, Sitruk-Ware R. Brache V, et al. Among authors: sitruk ware r. Contraception. 2021 Oct;104(4):327-336. doi: 10.1016/j.contraception.2021.06.010. Epub 2021 Jun 19. Contraception. 2021. PMID: 34157312 Free PMC article. Clinical Trial.
Continuous dosing of a novel contraceptive vaginal ring releasing Nestorone® and estradiol: pharmacokinetics from a dose-finding study.
Jensen JT, Edelman AB, Chen BA, Archer DF, Barnhart KT, Thomas MA, Burke AE, Westhoff CL, Wan LS, Sitruk-Ware R, Kumar N, Variano B, Blithe DL. Jensen JT, et al. Contraception. 2018 May;97(5):422-427. doi: 10.1016/j.contraception.2018.01.012. Epub 2018 Feb 2. Contraception. 2018. PMID: 29409834 Free PMC article. Clinical Trial.
195 results